Clincosm LogoSign in Get a demo

Type 2 Diabetes

Showing NaN - NaN of 69
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes, Chronic Kidney Disease Trial in Worldwide (Dulaglutide, Insulin glargine, Insulin lispro)

Completed
Has Results
  • Type 2 Diabetes
  • Chronic Kidney Disease
  • Montgomery, Alabama
  • +88 more
Sep 6, 2019

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
Has Results
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Hypercholesterolemia, Mixed Dyslipidemia, Type 2 Diabetes Trial in Worldwide (Evolocumab, Placebo to Evolocumab)

Completed
Has Results
  • Hypercholesterolemia
  • +2 more
  • Evolocumab
  • Placebo to Evolocumab
  • Tuscumbia, Alabama
  • +65 more
Aug 2, 2018

Type 2 Diabetes Trial in United States (ISIS-GCGRRx- Dose Level 1, ISIS-GCGRRx- Dose Level 2, Placebo)

Completed
  • Type 2 Diabetes
  • ISIS-GCGRRx- Dose Level 1
  • +2 more
  • Greenbrae, California
  • +18 more
Jun 20, 2018

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Sitagliptin)

Completed
Has Results
  • Type 2 Diabetes
  • Mesa, Arizona
  • +78 more
May 29, 2018

Type 2 Diabetes Trial in Puerto Rico, United States (INCB013739, Placebo comparator matching INCB013739, Metformin)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +67 more
Feb 12, 2018

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Metformin XR, Dapagliflozin)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +138 more
Mar 29, 2017

Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide (HOE901/AVE0010), Insulin glargine (HOE901), Metformin

Completed
Has Results
  • Type 2 Diabetes
  • Insulin glargine/lixisenatide (HOE901/AVE0010)
  • +2 more
  • Birmingham, Alabama
  • +235 more
Mar 31, 2017

Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide Fixed Ratio Combination, Insulin glargine (HOE901),

Completed
Has Results
  • Type 2 Diabetes
  • Insulin glargine/lixisenatide Fixed Ratio Combination
  • +3 more
  • Phoenix, Arizona
  • +272 more
Mar 31, 2017

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Placebo (Saxagliptin), Metformin IR)

Completed
Has Results
  • Type 2 Diabetes
  • Los Angeles, California
  • +15 more
Mar 7, 2017

Type 2 Diabetes, Obesity Trial in Los Angeles (Lottery Insurance, Standard Lottery)

Completed
  • Type 2 Diabetes
  • Obesity
  • Lottery Insurance
  • Standard Lottery
  • Los Angeles, California
    QueensCare Family Clinics
Mar 31, 2017

Obesity, Type 2 Diabetes, Cardiovascular Risk Trial in Los Angeles (Nutrition, Strength Training & Nutrition)

Completed
  • Obesity
  • +3 more
  • Nutrition
  • Strength Training & Nutrition
  • Los Angeles, California
    Veronica Atkins Lifestyle Intervention Laboratory
Mar 29, 2017

Obesity, Type 2 Diabetes, Cardiovascular Risk Trial in Los Angeles (Nutrition, Strength Training & Nutrition, Circuit Training &

Completed
  • Obesity
  • +3 more
  • Nutrition
  • +2 more
  • Los Angeles, California
    Veronica Atkins Lifestyle Intervention Laboratory
Mar 29, 2017

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin, Thiazolidinedione (Pioglitazone))

Completed
Has Results
  • Type 2 Diabetes
  • Anniston, Alabama
  • +88 more
Jan 3, 2017

Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)

Terminated
Has Results
  • Type 2 Diabetes
  • Obesity
  • EndoBarrier
  • Sham Procedure
  • Birmingham, Alabama
  • +24 more
Dec 2, 2016

Type 2 Diabetes Trial in United States (Bydureon, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Anaheim, California
  • +28 more
Dec 5, 2016

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo-matching dapagliflozin)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +328 more
Dec 2, 2016

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +297 more
Nov 10, 2016

Type 2 Diabetes, Hyperlipidemia Trial in United States (Colesevelam HCl, rosiglitazone maleate, sitagliptin phosphate)

Completed
Has Results
  • Type 2 Diabetes
  • Hyperlipidemia
  • Colesevelam HCl
  • +2 more
  • La Mesa, California
  • +19 more
Aug 23, 2016

Type 2 Diabetes, Obesity Trial in Los Angeles, San Antonio (rechargeable TANTALUS II)

Completed
  • Type 2 Diabetes
  • Obesity
  • rechargeable TANTALUS II
  • Los Angeles, California
  • +1 more
Sep 21, 2016

Impaired Glucose Tolerance, Type 2 Diabetes Trial in United States (Pioglitazone, Placebo)

Completed
Has Results
  • Impaired Glucose Tolerance
  • Type 2 Diabetes
  • Phoenix, Arizona
  • +7 more
Jun 29, 2016

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching with Dapagliflozin, Saxagliptin)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +66 more
May 18, 2016

Type 2 Diabetes Trial in Worldwide (ITCA 650 60 mcg/day, sitagliptin)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +53 more
May 13, 2016

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Metformin IR)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +83 more
Mar 24, 2016

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo, Metformin)

Completed
Has Results
  • Type 2 Diabetes
  • Tempe, Arizona
  • +74 more
Sep 30, 2015